Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Minichromosome maintenance proteins 7 (MCM7) are members of the family of minichromosome maintenance proteins (MCMs). MCMs are a class of highly conserved proteins that were first discovered in yeast and subsequently confirmed to be present in eukaryotic cell biology. The MCMs family consists of at least six members: MCM2, MCM3, MCM4, MCM5, MCM6 and MCM7. They have a similar structure and function, participate in the replication and extension of DNA, ensure that DNA is replicated only once per cell cycle, and is closely related to cell proliferation.
The Role of MCM7
The MCM2-7 complex has an extremely important function in DNA replication and is also a focal point for many signaling pathways during cell growth. The MCM4/MCM6/MCM7 complex has ssDNA-dependent ATPase activity, ATP-dependent ssDNA binding activity, and DNA dextran activity. The formation of tumors is caused by various physical and chemical factors, growth factors, proto-oncogenes and other conditions, resulting in uncontrolled cell cycle, abnormal cell differentiation and proliferation. Therefore, MCM7 regulates the cell cycle in G1 and S phases. Cell production, proliferation and tumor formation are closely related.
The ATPase motif of MCM7 is the key to the MCM4 / MCM6 / MCM7 complex. In addition to the common central structure, MCM7 also has a special structure, the zinc finger motif, which exists only in the MCM2 / MCM4 / MCM6 / MCM7 complex and is an essential structure for the regulation of the melting enzyme. Studies have shown that the mRNA level of MCM7 is consistent with the cell cycle, which can be detected significantly in G1 and S phases, but its expression level is gradually decreased or even undetectable in G0 phase and differentiation and senescence. Therefore, MCM7 can be used as a reliable marker for cell proliferation and is one of the basis for diagnosis of tumors.

Figure 1. Roles of MCM phosphorylation mediated by p56Lyn, Akt and ILK in cancer development. (Liangru, et al. 2018)
MCM7 Related Protein
In the cell cycle, CDK can actively phosphorylate MCMs, inactivate the helicase of MCM4 / MCM6 / MCM7, and regulate DNA replication. The regulation of mitotic kinase integrates the MCM2-7 complex into the chromatin; the MCM2-7 complex is treated to be an active helicase at the replication fork by a coordinated action of cdc7/dbf4 and cyclin E/Cdk2 in the G1-S phase transition, initiating DNA replication. Normally, when the cells enter the S phase, the complex is decomposed under the action of high CDK activity to inhibit DNA replication. Thus, in the cell cycle, p16 and MCM7 participate in cell cycle regulation through interaction with CKD, allowing DNA replication and cell proliferation to be performed accurately and orderly.
The receptor for activated C kinase 1 (RACK1) and MCM7 is involved in and regulate the cell cycle. There are multiple phosphorylation sites in the MCM7 and MCMs complex, and phosphorylated MCM7 plays an important role in DNA replication. It was found that RACK1 promotes phosphorylation of the silk/threonine site in MCM7, and phosphorylation of MCM7 promotes cell entry from the G1 phase to the S phase, promoting cell proliferation. A large number of studies have shown that RACK1 is expressed in most tumors, such as breast cancer, ovarian cancer, liver cancer, oral squamous cell carcinoma and malignant melanoma, and promotes tumor formation.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.